Enantioselective assay – really? [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2021-09-27 15:55 (26 d 13:30 ago) – Posting: # 22602
Views: 396

Hi qualityassurance,

I agree with Dshah’s post.

From my collection of strange stories: Prior to the 2010 BE-GL a couple of my studies of a certain drug were accepted with an achiral method. Approved in 47 countries. However, since the second condition was unknown, in subsequent studies we used an enantioselective method. It turned out that one enantiomer accounted for >95% of the total AUC.AFAIK, none of the product-specific guidances recommend a chiral assay…

» The question is related to product-specific bioequivalence guidance (EMA) for Ibuprofen…

The enantiomeric interconversion of ibuprofen is extremely fast. IMHO, dexibuprofen is a mere marketing joke.

Dif-tor heh smusma 🖖
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

 Admin contact
21,753 posts in 4,548 threads, 1,544 registered users;
online 5 (0 registered, 5 guests [including 4 identified bots]).
Forum time: Sunday 05:25 CEST (Europe/Vienna)

They were “so intent of making everything numerical”
that they frequently missed seeing
what was there to be seen.    Barbara McClintock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz